PEPFAR and CIFF Launch $200 million Accelerating Children’s HIV/AIDS Treatment Initiative (ACT) to Save Lives
Thursday, August 7, 2014
Today, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), in partnership with the Children’s Investment Fund Foundation (CIFF), launched Accelerating Children’s HIV/AIDS Treatment (ACT). ACT is an ambitious $200 million initiative to double the total number of children receiving life-saving antiretroviral therapy (ART) across ten priority African countries over the next two years. This investment will enable 300,000 more children living with HIV to receive ART.
“ACT is the right thing to do, it will save children’s lives,” said Heather Higginbottom, U.S. Deputy Secretary of State. “It is also the smart thing to do. Healthy children who can pursue their dreams are Africa’s future – they will grow economies, create jobs, and contribute to their families and communities for decades to come.”
In 2013, 3.2 million children under the age of 15 were living with HIV globally – 91 percent of whom were in sub-Saharan Africa. Yet, only 24 percent of these children are receiving ART. Children living with HIV are one-third less likely to receive ART compared to adults. Without ART, half of the children living with HIV will die before their second birthday, and 80 percent will die before their fifth birthday.
“This situation must be changed,” said Ambassador Deborah L. Birx, M.D., U.S. Global AIDS Coordinator. “Together, we must act swiftly, and with a focus on impact and geographic efficiency, to hasten the day when no child dies of AIDS. PEPFAR is committed to helping achieve an AIDS-free generation, and ACT is a bold step in that direction.”
ACT will target the countries with the highest burden of pediatric HIV, the lowest access to pediatric treatment, and the greatest disparity in treatment coverage for children compared to adults living with HIV. The PEPFAR-CIFF partnership will jointly invest $200 million in ACT, $150 million from PEPFAR and up to $50 million from CIFF.
Source: PEPFAR (link opens in a new window)
- Health Care